UGN-201
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UGN-201, covering 2026-03-18 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630 [Phase 1]